-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 WJxJTvwUZr8Q9Oh8BDmtyFkq4a1Dcha5YtncALYlaU1HCfABiWWEkZGK2u2nDt8y
 VokEGVR4Hleg7UMP+U+F/A==

<SEC-DOCUMENT>0001104659-09-056604.txt : 20100818
<SEC-HEADER>0001104659-09-056604.hdr.sgml : 20100818
<ACCEPTANCE-DATETIME>20090928164500
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0001104659-09-056604
CONFORMED SUBMISSION TYPE:	CORRESP
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20090928

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BIO KEY INTERNATIONAL INC
		CENTRAL INDEX KEY:			0001019034
		STANDARD INDUSTRIAL CLASSIFICATION:	COMPUTER COMMUNICATIONS EQUIPMENT [3576]
		IRS NUMBER:				411761861
		STATE OF INCORPORATION:			MN
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		CORRESP

	BUSINESS ADDRESS:	
		STREET 1:		3349 HIGHWAY 138
		STREET 2:		BUIDING D, SUITE B
		CITY:			WALL
		STATE:			NJ
		ZIP:			07719
		BUSINESS PHONE:		6516870414

	MAIL ADDRESS:	
		STREET 1:		3349 HIGHWAY 138
		STREET 2:		BUIDING D, SUITE B
		CITY:			WALL
		STATE:			NJ
		ZIP:			07719

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SAC TECHNOLOGIES INC
		DATE OF NAME CHANGE:	19961115
</SEC-HEADER>
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>

<html>

<head>





</head>

<body lang="EN-US">

<div style="font-family:Times New Roman;">

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman"><img width="192" height="96" src="g277941gai001.jpg"></font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-weight:bold;margin:0in 0in .0001pt;text-autospace:none;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">September&nbsp;28, 2009</font></b></p>

<p style="font-weight:bold;margin:0in 0in .0001pt;text-autospace:none;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></b></p>

<p style="font-weight:bold;margin:0in 0in .0001pt;text-autospace:none;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;">VIA
EDGAR AND OVERNIGHT MAIL</font></b></p>

<p style="font-weight:bold;margin:0in 0in .0001pt;text-autospace:none;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></b></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Securities
and Exchange Commission</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Division
of Corporation Finance</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">100
F Street, N.E.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Washington,
D.C. 20549-0309</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Attn.:&#160; Michael F. Johnson, Staff Attorney</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">RE:</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">BIO-key
International,&nbsp;Inc.<br>
Preliminary Proxy Statement on Schedule 14A<br>
<u>Filed on September&nbsp;1, 2009 (File No.&nbsp;001-13463)</u></font></p>

<p style="margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Ladies and Gentlemen:</font></p>

<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">On behalf of our client, </font><font size="2" style="font-size:10.0pt;">BIO-key International,&nbsp;Inc.</font><font size="2" style="font-size:10.0pt;"> (the &#147;<u>Company</u>&#148;),
we are responding to the comments of the Staff (the &#147;<u>Staff</u>&#148;) of the
Division of Corporation Finance of the Securities and Exchange Commission (the &#147;<u>Commission</u>&#148;)
set forth in your letter dated September&nbsp;15, 2009 (the &#147;<u>Comment Letter</u>&#148;)
to Mr.&nbsp;Michael W. DePasquale, Chief Executive Officer of the Company, with
respect to the Company&#146;s </font><font size="2" style="font-size:10.0pt;">Preliminary Proxy Statement on Schedule 14A</font><font size="2" style="font-size:10.0pt;"> (File No.&nbsp;</font><font size="2" style="font-size:10.0pt;">001-13463</font><font size="2" style="font-size:10.0pt;">), which was filed with the
Commission on</font><font size="2" style="font-size:10.0pt;"> September&nbsp;1,
2009</font><font size="2" style="font-size:10.0pt;"> (the &#147;<u>Proxy Statement</u>&#148;)</font><font size="2" style="font-size:10.0pt;">.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The
responses set forth below have been organized in the same manner in which the
Staff&#146;s comments were organized in the Comment Letter.&#160; For ease of reference, the Staff&#146;s comments
are set forth below in bold, followed by the Company&#146;s responses.&#160; Pursuant to the Staff&#146;s request included in
the Comment Letter, the Company has also filed an amended Preliminary Proxy
Statement on Schedule 14A (the &#147;<u>Amendment</u>&#148;) on the date hereof, which
reflects the changes discussed below.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Questions and Answers About the Asset Sale and the
Special Meeting</font></u></b></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Why am I receiving this proxy statement? page&nbsp;7</font></u></b></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">1.</font></b><b><font size="1" style="font-size:3.0pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></b><b><font size="2" style="font-size:10.0pt;font-weight:bold;">You
state that you intend to use the sale proceeds to redeem your convertible
preferred stock and for general working capital purposes.&#160; Please clarify here, and elsewhere as
applicable, whether you intend to use</font></b></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Two
International Place | Boston MA 02110 | <b>t</b> 617-248-5000
| <b>f</b> 617-248-4000 | <b>choate.com</b></font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\jmathew\09-27794-1\task3731764\27794-1-ga.htm',USER='105205',CD='Sep 29 01:00 2009' -->


<br clear="all" style="page-break-before:always;">


<div style="font-family:Times New Roman;">

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt 1.0in;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">the proceeds to repay the remainder of the $2,164,922 liability to
Longview Special Finance,&nbsp;Inc. and Longview Fund, L.P., and to redeem the
convertible preferred shares currently held by The Shaar Fund, Ltd.</font></b></p>

<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt 1.0in;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In response to
this comment, the Company has included additional language where applicable in
the Amendment to clarify that following the completion of the Asset Sale, the
Company intends to use the sale proceeds (i)&nbsp;to pay the remainder of its
outstanding liability (equal to $1,082,461 plus accrued and unpaid interest) to
Longview Special Finance,&nbsp;Inc. and Longview Fund, L.P., (ii)&nbsp;to pay
the outstanding amount due under its unsecured promissory note issued to The
Shaar Fund, Ltd. (equal to $1,000,000 plus accrued and unpaid interest), (iii)&nbsp;to
redeem all outstanding shares of its Series&nbsp;B and C Convertible Preferred
Stock, portions of which are currently held by The Shaar Fund, Ltd., and (iv)&nbsp;for
general working capital purposes.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Why did BlO-key enter into the
Asset Purchase Agreement? page&nbsp;7</font></u></b></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">2.</font></b><b><font size="1" style="font-size:3.0pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></b><b><font size="2" style="font-size:10.0pt;font-weight:bold;">You
state that after &#147;due consideration of all other alternatives reasonably
available to BIO-key, the BIO-key board of directors concluded that the
completion of the Asset Sale was the best available alternative reasonably
likely to enable BIO-key to satisfy its outstanding liabilities and obligations
and to maximize value to its stockholders.&#148;&#160;
Please consider expanding your discussion here, and elsewhere as
applicable, to provide a brief description of the &#147;other alternatives&#148; available
to BIO-key that were considered by BIO-key&#146;s board of directors and the reasons
for rejecting these alternatives.</font></b></p>

<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt 1.0in;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In response to
this comment, the Company has included additional language in the Amendment to
clarify that those other alternatives included a private placement of
securities or the issuance of non-convertible debt and that those alternatives
were ultimately rejected by the BIO-key board because they would have required
significant ongoing dividend or interest obligations.</font></p>

<p style="margin:0in 0in .0001pt 1.0in;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Do BIO-key&#146;s directors and
officers have any interest in the Asset Sale? page&nbsp;9</font></u></b></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">3.</font></b><b><font size="1" style="font-size:3.0pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></b><b><font size="2" style="font-size:10.0pt;font-weight:bold;">We note
that Mr.&nbsp;Souza may be entitled to payments under his employment agreement
as a result of the asset sale.&#160; Please
revise your filing to quantify the payments Mr.&nbsp;Souza will receive should
the asset sale be consummated and his employment with BIO-key terminated.</font></b></p>

<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Mr.&nbsp;Souza
will not receive any payment under his employment agreement with the Company as
a result of the Asset Sale.&#160; The Company
has revised the Proxy Statement to clarify that InterAct has agreed to assume
the Company&#146;s </font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2</font></p>

<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='2',FILE='C:\JMS\jmathew\09-27794-1\task3731764\27794-1-ga.htm',USER='105205',CD='Sep 29 01:00 2009' -->


<br clear="all" style="page-break-before:always;">


<div style="font-family:Times New Roman;">

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">obligations
to Mr.&nbsp;Souza under that employment agreement following the Asset Sale and
it is anticipated that Mr.&nbsp;Souza will become an employee of InterAct.</font></p>

<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Cautionary Statements Regarding Forward-Looking Statements, page&nbsp;20</font></u></b></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">4.</font></b><b><font size="1" style="font-size:3.0pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></b><b><font size="2" style="font-size:10.0pt;font-weight:bold;">We note
your statement that your proxy statement, and the documents to which you refer
in the proxy statement, contain forward-looking statements &#147;within the meaning
of the Private Securities Litigation Reform Act of 1995.&#148;&#160; Section&nbsp;21E(b)(1)(C)&nbsp;of the
Securities Exchange Act of 1934 expressly states that the safe harbor for
forward-looking statements does not apply to statements made by issuers of
penny stock.&#160; Please either delete any
references to the safe harbors provided by the Litigation Reform Act or make
clear, each time you refer to the safe harbors provided by Litigation Reform
Act, that the safe harbor does not apply to issuers of penny stock.</font></b></p>

<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The
Company has deleted all references in the Proxy Statement to the safe harbors
provisions of the Litigation Reform Act.</font></p>

<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Effects of the Asset Sale, page&nbsp;30</font></u></b></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">5.</font></b><b><font size="1" style="font-size:3.0pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></b><b><font size="2" style="font-size:10.0pt;font-weight:bold;">Please
expand the discussion regarding your continuing business, i.e., advanced
fingerprint identification biometric technology and software solutions, to
provide a more detailed textual discussion of the assets and liabilities being
retained.&#160; Discuss how management plans
to conduct business following the asset sale and provide a balanced discussion
of management&#146;s views as to not only the opportunities afforded by, but also
the challenges with respect to, the retained business activities. Refer to Item
303 of Regulation S-K in considering the appropriate historical as well as
prospective information about the financial performance and business activities
of the ongoing business.</font></b></p>

<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In
response to this comment, the Company has included additional language in the
Amendment regarding its continuing business.&#160;
Specifically, the BIO-key board believes, as evidenced by the Company&#146;s
recent award by Lockheed Martin to provide its fingerprint technology for the
FBI&#146;s Next Generation Identification system, that its biometrics solutions have
gained market acceptance and that this sector presents significant
opportunities for growth. &#160;Nevertheless,
the overall size of the biometrics market remains uncertain and BIO-key will
continue to face challenges from a variety of competitors including those with
greater resources than BIO-key.&#160; See Risk
Factors Relating to BIO-key beginning on page&nbsp;14 of the Amendment.</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3</font></p>

<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='3',FILE='C:\JMS\jmathew\09-27794-1\task3731764\27794-1-ga.htm',USER='105205',CD='Sep 29 01:00 2009' -->


<br clear="all" style="page-break-before:always;">


<div style="font-family:Times New Roman;">

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Proposal One &#151; Asset Sale</font></u></b></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Consideration to be received, page&nbsp;32</font></u></b></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">6.</font></b><b><font size="1" style="font-size:3.0pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></b><b><font size="2" style="font-size:10.0pt;font-weight:bold;">We note
your statement that you intend to use the sale proceeds to redeem your
convertible preferred stock and for general working capital purposes.&#160; However, elsewhere in your filing you
indicate that your shareholders will receive consideration in connection with
the asset sale.&#160; Please address the
consideration to be received by shareholders in the forepart of the document,
such as in the summary term sheet.&#160; If
they will not receive any consideration, please include a clear statement to
this effect.</font></b></p>

<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In
response to this comment, the Company has included a clear statement on page&nbsp;33
of the Amendment indicating that the Company&#146;s stockholders will not directly
receive any of the proceeds of the Asset Sale.</font></p>

<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Representations and Warranties, page&nbsp;33</font></u></b></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">7.</font></b><b><font size="1" style="font-size:3.0pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></b><b><font size="2" style="font-size:10.0pt;font-weight:bold;">We note
your disclosure on page&nbsp;33 that the representations and warranties may
have been modified by the confidential disclosure schedules delivered
separately from the asset purchase agreement. General disclaimers regarding the
accuracy and completeness of disclosure are not sufficient when the company is
aware of material contradictory information, and additional disclosure by the
company is appropriate in such circumstances. Please revise the disclaimer to
include a clear statement of your disclosure responsibilities with regard to
material contradictory information.</font></b></p>

<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In
response to this comment, the Company has deleted the disclaimer language
included on page&nbsp;33 of the Amendment.</font></p>

<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">8.</font></b><b><font size="1" style="font-size:3.0pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></b><b><font size="2" style="font-size:10.0pt;font-weight:bold;">The
third sentence under &#147;Representations and Warranties&#148; states that the
representations and warranties of each of BlO-key and InterAct have been made
solely for the benefit of the party or parties to which they have been made,
and &#147;should not be relied upon by any other person.&#148;&#160; Inclusion of representations and warranties
in the asset purchase agreement, which has been filed with the Commission,
constitutes disclosure to investors.&#160; To the
extent that you are aware of additional material facts that contradict or
qualify the disclosure of the original representation, you must disclose
them.&#160; See Release 34-51283.&#160; Please delete the phrase suggesting that
shareholders should not rely on this information.</font></b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4</font></p>

<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='4',FILE='C:\JMS\jmathew\09-27794-1\task3731764\27794-1-ga.htm',USER='105205',CD='Sep 29 01:00 2009' -->


<br clear="all" style="page-break-before:always;">


<div style="font-family:Times New Roman;">

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In
response to this comment, the Company has deleted the phrase suggesting that
shareholders should not rely on this information.</font></p>

<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">9.</font></b><b><font size="1" style="font-size:3.0pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></b><b><font size="2" style="font-size:10.0pt;font-weight:bold;">Cautionary
language should be limited to statements of fact.&#160; In contrast, much of the disclaimer contains
statements of speculation; in effect, that the representations and warranties
in the asset purchase agreement:</font></b></p>

<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt 1.25in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font size="2" style="font-size:10.0pt;font-weight:bold;">Are
subject to qualifications and <u>limitations</u> by the respective parties,
including <u>exceptions</u> and other information that are not necessarily
reflected in the filed agreement &#151; but you will not tell investors which
representations or warranties, if any, have been so qualified, limited or
excepted; and</font></b></p>

<p style="margin:0in 0in .0001pt 1.25in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt 1.25in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font size="2" style="font-size:10.0pt;font-weight:bold;">May&nbsp;have
changed after the date of the merger agreement &#151; but you will not tell
investors what, if anything, has changed.</font></b></p>

<p style="margin:0in 0in .0001pt 1.25in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">The intent and the effect of the language used in the second and fourth
sentences of the first paragraph under &#147;Representations and Warranties&#148; is to
undermine and to put into question the interpretation and reliability of a
document that the Commission has required you to file as an appendix to your
proxy statement.&#160; Either specifically
identify which representations and warranties are subject to this language or
delete this language.</font></b></p>

<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In
response to this comment, the Company has deleted the language identified by
the Staff.</font></p>

<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Unaudited Pro Forma Condensed Consolidated Financial Information, page&nbsp;71</font></u></b></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">10.</font></b><b><font size="1" style="font-size:3.0pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></b><b><font size="2" style="font-size:10.0pt;font-weight:bold;">Revise
your filing to include your financial statements and the unaudited financial
statements of the business being disposed of, i.e., the Law Enforcement
Division.&#160; See Section&nbsp;H Question 6
of the Division of Corporation Finance&#146;s July&nbsp;2001 Third Supplement to the
Manual of Publicly Available Telephone Interpretations.</font></b></p>

<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The
Company has revised the Proxy Statement to include its financial statements and
the unaudited financial statements of the Law Enforcement Division.</font></p>

<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">11.</font></b><b><font size="1" style="font-size:3.0pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></b><b><font size="2" style="font-size:10.0pt;font-weight:bold;">Please
tell us how you considered including the financial information for
InterAct.&#160; In this regard, we note that
BIO-key will receive a promissory note in the original principal mount of
$4,000,000 issued by InterAct, </font></b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5</font></p>

<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='5',FILE='C:\JMS\jmathew\09-27794-1\task3731764\27794-1-ga.htm',USER='105205',CD='Sep 29 01:00 2009' -->


<br clear="all" style="page-break-before:always;">


<div style="font-family:Times New Roman;">

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">guaranteed by InterAct911 Corporation and one of its owners SilkRoad
Equity, LLC.&#160; Refer to Item 14(c)(1)&nbsp;of
Schedule 14A.</font></b></p>

<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In
accordance with Instruction 3 to Item 14 of Schedule 14A, the Company does not
believe that any financial information for InterAct is required to be included
in the Proxy Statement under Item 14(c)(1)&nbsp;because the Company does not
believe that any such information is material to an informed voting
decision.&#160; InterAct was formed for the
sole purpose of acquiring the assets of the Company&#146;s Law Enforcement
division.&#160; It has no previous operating
history and no historical financial statements.&#160;
Moreover, the Company believes that InterAct will have sufficient funds
available to it when necessary in order to complete the Asset Sale transaction.&#160; That belief is supported by the
representation and warranty made by InterAct to the Company in the Asset
Purchase Agreement governing the Asset Sale that InterAct has access to
sufficient cash to enable it to consummate the transactions contemplated by
that agreement (including performing its obligations under the $4,000,000
promissory note to be issued by InterAct at the closing).&#160; In addition, the Company believes that the
intellectual property assets that secure the promissory note, when coupled with
the guarantees, provide the Company with sufficient security for repayment of
that note.</font></p>

<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">*&#160; *&#160;
*&#160; *</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The
Company hereby acknowledges that:</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt 1.0in;punctuation-wrap:simple;text-autospace:none;text-indent:-.25in;vertical-align:baseline;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">The Company is responsible
for the adequacy and accuracy of the disclosure in the Proxy Statement;</font></p>

<p style="margin:0in 0in .0001pt 1.0in;punctuation-wrap:simple;text-autospace:none;text-indent:-.25in;vertical-align:baseline;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt 1.0in;punctuation-wrap:simple;text-autospace:none;text-indent:-.25in;vertical-align:baseline;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Staff comments or changes to
disclosure in response to Staff comments do not foreclose the Commission from
taking any action with respect to the Proxy Statement; and</font></p>

<p style="margin:0in 0in .0001pt 1.0in;punctuation-wrap:simple;text-autospace:none;text-indent:-.25in;vertical-align:baseline;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">The Company may not assert Staff comments as
a defense in any proceeding initiated by the Commission or any person under the
federal securities laws of the United States.</font></p>

<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">If you have any questions
concerning these responses, need further supplementary information or if you
would like to discuss any of the matters covered in this letter, please contact
the undersigned at (617) 248-4020 or Brian J. Carr at (617) 248-4028.&#160; Thank you.</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6</font></p>

<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='6',FILE='C:\JMS\jmathew\09-27794-1\task3731764\27794-1-ga.htm',USER='105205',CD='Sep 29 01:00 2009' -->


<br clear="all" style="page-break-before:always;">


<div style="font-family:Times New Roman;">

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Very truly yours,</font></p>

<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
 <tr>
  <td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/
  Charles J. Johnson</font></p>
  </td>
  <td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="50%" valign="top" style="border:none;padding:0in 0in 0in 0in;width:50.0%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Charles
  J. Johnson</font></p>
  </td>
  <td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
</table>

<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">cc:</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Maryse
Mills-Apenteng (at SEC)</font></p>

<p style="margin:0in 0in .0001pt .5in;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Thomas
J. Colatosti</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">7</font></p>

<div style="margin:0in 0in .0001pt;text-indent:0in;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='7',FILE='C:\JMS\jmathew\09-27794-1\task3731764\27794-1-ga.htm',USER='105205',CD='Sep 29 01:00 2009' -->


</body>

</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g277941gai001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g277941gai001.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``H'!P@'!@H("`@+"@H+#A@0#@T-
M#AT5%A$8(Q\E)"(?(B$F*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_
MP``+"`!@`,`!`1$`_\0`'P```04!`0$!`0$```````````$"`P0%!@<("0H+
M_\0`M1```@$#`P($`P4%!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$(
M(T*QP152T?`D,V)R@@D*%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%56
M5UA96F-D969G:&EJ<W1U=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBI
MJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W
M^/GZ_]H`"`$!```_`/86N(UNH[8Y\R1&=>.,*0#_`.A"I:**A2YCDN9;=<[X
M0I;CCYLX_E4U%%0V]S'=+(8\XCD:-LC'*G!J:BD)P"3VJ.VN([NUBN8L^7*@
M=<C!P1FI:*ANKF.SMGN)<[(QDX&34U%%0SW,=NT0DSF:01K@=R"?Z5-11437
M$:W:6QSYCQM(..,*0#_Z$*JS?\A^T_Z]IO\`T*.K]%%9UI_R'=0_ZYP_^S5H
MT45G:-_JKO\`Z_)O_0JT:*:_W&^E4M#_`.0#8?\`7NG_`*"*OT5G:_\`\@.[
M_P!S^HK1HHK.U;_6Z=_U^+_Z"U:-%%4)?^1AMO\`KTF_]#BHF_Y#]I_U[3?^
MA1U?HHK.M/\`D.ZA_P!<X?\`V:M&BBL[1O\`57?_`%^3?^A5HT4U_N-]*I:'
M_P`@&P_Z]T_]!%7Z*SM?_P"0'=_[G]16C116=JW^MT[_`*_%_P#06K1HHJA+
M_P`C#;?]>DW_`*'%1-_R'[3_`*]IO_0HZOT45G6G_(=U#_KG#_[-6C116=HW
M^JN_^OR;_P!"K1HIK_<;Z52T/_D`V'_7NG_H(J_16=K_`/R`[O\`W/ZBM&BB
ML[5O];IW_7XO_H+5HT450E_Y&&V_Z])O_0XJ)O\`D/VG_7M-_P"A1U?HHK.M
M/^0[J'_7.'_V:M&BBL[1O]5=_P#7Y-_Z%6C137^XWTJEH?\`R`;#_KW3_P!!
M%7Z*SM?_`.0'=_[G]16C116=JW^MT[_K\7_T%JT:**H2_P#(PVW_`%Z3?^AQ
M43?\A^T_Z]IO_0HZI^*_%5AX1T@W][EV8[(84/S2MZ#T]SVKSV/Q_P#$?48/
M[4T_PO&=/^\H\IF++Z@[@3]0*ZWP)\0;7QC'+;R0?8]1MQF2`G(8=-RGZ]0>
ME;]I_P`AW4/^N</_`+-7,R^.;Z/XHIX3%I;FU90?.RWF?ZO?].M='XFU671/
M#=_JD$:226L)D5'SM)'KBL_P'XEN?%?AI-4NX(H)6E=-D1.W`/O6GHW^JN_^
MOR;_`-"KC/%WQ1?3-8.@^'=/_M/40VQS@E5;^Z`.6([]A6./B?XO\/W,1\5^
M&_*M)3C?&A1A]"203[<5ZC8:C:ZMI<6H64HEM[B/>CCN/\:CT/\`Y`-A_P!>
MZ?\`H(K`^(?C63P9I=M-;017%U<R[4CE)`V@98\?A^='P\\:/XSTJXGN8(H+
MJVEV/'$3C:1E3S^/Y5NZ_P#\@.[_`-S^HJ36;JZLM&O+JQM_M-U#"SQ0X)\Q
M@.!QS7E6H?%GQGI(C.I>%H+,2DA/.21=Q'7&373>$?%OB_6=;6UUGPR=/LVB
M9O/\MQR.@R>.:ZO5O];IW_7XO_H+57\7:U-X>\+WVK6\4<LML@94DSM.6`YQ
M]:\[L_B=X[U&U6ZLO""7,#YVRQ1RLIP<'G-=/X,\4>*];U:6VUWPX=,ME@+K
M*8W7<V0-OS>Q/Y5T\O\`R,-M_P!>DW_H<5$W_(?M/^O:;_T*.O+_`(FH-2^)
MOAW2KP_Z&PCRI/!W2$-^84"O7418T5$4*JC`4#``K,M_#&B6FL/J]OIL$5_(
M6+3H,,<]?SJ2T_Y#NH?]<X?_`&:O'_%VHW^E?&J2]TNQ-]=Q(GEVX!._,6#P
M.>A)JQXB\<^-=0\/7UG?^$'M+6:$K+.8I!Y:^O/%=;\&_P#D0(O^OF7^==+8
MR-#I^HRH,NEQ.RCW!->=?`^U@N9=8U:<"2]\Q4WMR5#98G\3_*O0_%]A:ZEX
M3U.WO%4Q?9G?)_A902&'T(KC?@E<S2^#KR&0DQPW3"//;*@D?G_.N\T/_D`V
M'_7NG_H(KRWQ#(GB[XSV6F,RFRTK'F;C\OR_._YG:OX4>&9$\(_&2^TD,HL]
M3)\K!X^;YT_([E_&O4-?_P"0'=_[G]16C7D_QT_X]]#_`.NTG\EKU2#_`(]X
M_P#<'\JI:M_K=._Z_%_]!:L;XF_\D[U?_KDO_H:UYQX/\5^.-,\,VUIHWAC[
M=9(7\N?RG.[+$GD''!R*],\%:SXAUFQN9?$.D?V9-'*%B38R[UQUY)[UK2_\
MC#;?]>DW_H<5$P/]O6IP<"WFR<<?>CKD_B=X+NO$ME;ZAI1QJ=@28US@R+G.
M`>Q!&1^-<[!\7=>L+,6&I>%KB35(QLW89`Q]2NW/Y5M?#S3?%MWJ5QXA\37E
MW$DP/D6#N0HS_$4_A`'`'XUV=JI&MZ@2#@QPX..OWJ\XN+2Z/[0,5R+:;R-@
M_>^6=G^I(Z]*[?QW&\O@;6(XD9W:U8!5!)/T`K'^$$$UOX$BCGADA?[1*=LB
M%3U]#73Z0I$5V&4C-W-U'4;J\JO])\1_##Q3<ZOH=DU_I%V27B52P4$YVL!R
M"">&]*9K/CCQ1X_M3H6B>'Y[6.XPL[DDY'<%B`%7UKTKP?X9C\)^&(=,5Q)*
M`9)Y`.'D/7'MT`^E3P7G]E^#H[QXW8V]D'\L*2Q(7ICKFO(O!_PVF\:07VKZ
MU<W=A))<':!'AG)Y8G<.F3_.CQ?\-Y_!45AJ^BW-W?R1W(W`QY9"/F4C:.F0
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M=)";>'4Y$N+DM`C>7NG9L?NP>A/J:M:>G[S=Y5[&=O\`R\3;@?PW'FEENY8=
M4>-8)ID\E6Q'MPIW-ZD?Y%49]1D-C.KRRVTD]T848C+1#`)(QGH`<>^*LV5\
MUW]A</\`?6190.`67`/ZYJTTCC5(X]QV&!F*]L[EY_6I;B9+>WDFD;:J*23C
M./PK+T2>99)+>\=TN"`?)D<NW`Y?/8'(X'`QCUJQJ"3-<H=LTL"H=T<$NQ@V
M>IY&1^-5VB$R6+B\NF\R4QN?,:,D!7X(!X((&?I0RLU_<1E+^18V15,4Y"@;
M!_M#FFWMQ=H)K*"9A/YPDC;J?+"[\?0E2OXTEUJ1D@FD2Y:)+AT@A=1DI\NY
MF'N`3^*BD-\;N"P9FN&#%UE%N64EE&.V#C//XBFN7FTR]D$UY$('(B#R,LB\
M#.>>>>1GL:V5B%O;,J.YP"07<L?S-5FFD_L`S;SYGV7=N[YVYS3M3D:/2I'5
MG#;1S&?FZCI[U%8B3[83&MVL'EG=]I8G+9&,9)/3.>W2KES:QW2!9-P*G<CJ
M<,I]0:A73+<*^\R2N^-TDC98@'('L,]A5B2".62-W&3&25_$8/Z&JJZ3;J5&
MZ4Q(05@,A*`CIQZ>W2IOL4!M#:E3Y9R3R<Y)SG/KGFE>TAD2=&!Q<#$G/7C;
M_(4V"S\A]WVB>3C&)'R*F$2"<S8^=E"DY[`D_P!34:6<$=P9U4[R6.<_WL9_
M]!%1RZ;#)*95>6)RQ;=&^.2`#^@%(VFHQC;[1<!XP5#B3D@D'!_*IC;1O:FV
MEW2HR[6WG)(^M01:9#%=)=&2:69%**\CDD*>J_3H?P%27%C'<2"422Q2`;=\
M38)'H?6E2R@CCA15.(6+KEB3N(.23WZFF2:>CSO,L\\1D(+".3`)`QT^@J3[
M'#]L6[VYF6/R@V?X<Y_G3+;3K6T$8ACVB(.$&2<;CD_K3Q9P"X^T!3OW%NO&
M2`#^@%#V<,B3HRDB<Y?GKP!_("IB`RE3T(P:IQZ7$D1A\^X>(QF/8TF1@C%.
573D"LDD\\JL`-LDF1US_`$JW7__9
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
